36052-25-2

Usage

Chemical Properties

Off-white solid

InChI:InChI=1/C7H8N2O2/c1-11-7(10)5-2-6(8)4-9-3-5/h2-4H,8H2,1H3

Upstream product

• 67-56-1 methanol 
• 24242-19-1 5-aminonicotinic acid 
• 499-81-0 3,5-Pyridinedicarboxylic acid 
• 29681-44-5 5-bromo-3-pyridine carboxylic acid methyl ester 
• 20826-04-4 5-bromo-3-pyridinecarboxylic acid 
• 18107-18-1 diazomethyl-trimethyl-silane 

Downstream Products

• 24242-19-1 5-aminonicotinic acid 
• 455-70-9 5-fluoro-3-pyridinecarboxylic acid methyl ester 
• 27828-71-3 5-hydroxynicotinic acid 
• 10177-13-6 methyl 5-phenylpyridine-3-carboxylate 
• 1617508-24-3 methyl 5-(benzylamino)nicotinate 
• 1617508-25-4 C₁₆H₁₈N₂O₄ 
• 959857-83-1 5-[2-(4-adamantan-1-yl-phenoxy)-acetylamino]-nicotinic acid methyl ester 
• 904295-32-5 5-{[5-(3,3-dimethyl-butyrylamino)-1-(2-fluoro-benzyl)-1H-indole-2-carbonyl]-amino}-nicotinic acid methyl ester 

Relevant academic research and scientific papers

A predictive model for additions to: N -alkyl pyridiniums

Disclosed in this communication is a thorough study on the dearomative addition of organomagnesium nucleophiles to N-alkyl pyridinium electrophiles. The regiochemical outcomes have observable and predictable trends associated with the substituent patterns on the pyridinium electrophile. Often, the substituent effects can be either additive, giving high selectivities, or ablative, giving competing outcomes. Additionally, the nature of the organometallic nucleophilic component was also investigated for its role in the regioselective outcome. The effects of either reactive component are important to both the overall reactivity and site of nucleophilic addition. The utility of these observed trends is demonstrated in a concise, dearomative synthesis of a tricyclic compound shown to have insecticidal activity. This journal is

ATP-REGULATED POTASSIUM CHANNEL OPENERS COMPRISING GUANIDINE AND USES THEREOF

The present invention provides compounds comprising an ATP-regulated potassium (KATP) channel opener, and pharmaceutical compositions thereof. These compounds and compositions are useful for prevention, treatment, or management of pulmonary arterial or venous hypertension.

FUSED PYRIMIDINE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF FIBROTIC DISEASES

The present invention discloses compounds according to Formula I: Wherein A, B, R1, R2, and Cy are as defined herein. The present invention relates to compounds inhibiting autotaxin (NPP2 or ENPP2), methods for their production, pharmaceutical compositions comprising the same, and methods of treatment using the same, for the prophylaxis and/or treatment of fibrotic diseases, proliferative diseases, inflammatory diseases, autoimmune diseases, respiratory diseases, cardiovascular diseases, neurodegenerative diseases, dermatological disorders, pain, and/or abnormal angiogenesis associated diseases by administering the compounds of the invention.

Photorelease of Pyridines Using a Metal-Free Photoremovable Protecting Group

The photorelease of bioactive molecules has emerged as a valuable tool in biochemistry. Nevertheless, many important bioactive molecules, such as pyridine derivatives, cannot benefit from currently available organic photoremovable protecting groups (PPGs). We found that the inefficient photorelease of pyridines is attributed to intramolecular photoinduced electron transfer (PET) from PPGs to pyridinium ions. To alleviate PET, we rationally designed a strategy to drive the excited state of PPG from S1 to T1 with a heavy atom, and synthesized a new PPG by substitution of the H atom at the 3-position of 7-dietheylamino-coumarin-4-methyl (DEACM) with Br or I. This resulted in an improved photolytic efficiency of the pyridinium ion by hundreds-fold in aqueous solution. The PPG can be applied to various pyridine derivatives. The successful photorelease of a microtubule inhibitor, indibulin, in living cells was demonstrated for the potential application of this strategy in biochemical research.

Efforts toward the synthesis of (+)-Lyconadin A

Abstract: Synthetic efforts toward the synthesis of (+)-lyconadin A are described. B-Alkyl Suzuki coupling is utilized for combining 2-iodo cyclohexenone with the piperidine subunit. The piperidine subunit is derived from 5-bromo-3-nicotinic acid, and iod

Discovery of 5-((5-chloro-2-methoxyphenyl)sulfonamido)nicotinamide (SBI-425), a potent and orally bioavailable tissue-nonspecific alkaline phosphatase (TNAP) inhibitor

Tissue-nonspecific alkaline phosphatase (TNAP) is an ectoenzyme crucial for bone matrix mineralization via its ability to hydrolyze extracellular inorganic pyrophosphate (ePPi), a potent mineralization inhibitor, to phosphate (Pi). B

SULFONAMIDE COMPOUNDS AND USES AS TNAP INHIBITORS

Described herein are compounds that modulate the activity of TNAP. In some embodiments, the compounds described herein inhibit TNAP. In certain embodiments, the compounds described herein are useful in the treatment of conditions associated with hyper- mineralization.

NOVEL AMINOPYRIDINE DERIVATIVES HAVING AURORA A SELECTIVE INHIBITORY ACTION

The present invention relates to a compound of Formula (I): wherein: R 1 is H, -NHCOOR 1a , C 5-6 cycloalkyl, or phenyl; where the cycloalkyl and phenyl each independently may be substituted with one to three of the same or different substituents selected from R 10 ; R 1a is C 1-3 alkyl which may be substituted with one to three of the same or different substituents selected from F and Cl; R 2 is H, -COOH, -CH 2 COOH, -COOR 2a , or -CH 2 COOR 2a ; R 2a is C 1-2 alkyl, where the alkyl may be substituted with one to three of the same or different substituents selected from halogen atoms; R 3 is H, C 1-6 alkyl, where the alkyl may be substituted with one to three of the same or different substituents selected from R 11 ; R 10 is F, Cl, CF 3 , or C 1-2 alkyl; R 11 is halogen atom, hydroxy, or cyano; W is selected from: W2a is H, halogen atom, cyano, C 1-2 alkyl, or C 3-5 cycloalkyl, or a pharmaceutically acceptable salt or ester thereof.

Facile synthesis of peptide-porphyrin conjugates: Towards artificial catalase

A facile synthetic method for peptide-porphyrin conjugates containing four peptide units on one porphyrin was developed using chemoselective reactions. The key building blocks, 5,10,15,20-tetrakis(3-azidophenyl)porphyrin 1 and 5,10,15,20-tetrakis(5-azido-3-pyridyl)porphyrin 2, were efficiently synthesized and used as substrates for two well-known chemoselective reactions, traceless Staudinger ligation and copper-catalyzed azide alkyne cycloaddition (so-called click chemistry). Both reactions gave the desired compounds, and click chemistry was superior for our purpose. To confirm the value of the established methodology, nine peptide-porphyrin conjugates were synthesized, and their catalase- and peroxidase-like activity in water was evaluated. Our synthetic strategy is expected to be valuable for the preparation of artificial heme protein models.

(3-HYDROXY-4-AMINO-BUTAN-2-YL) -3- (2-THIAZOL-2-YL-PYRROLIDINE-1-CARBONYL) BENZAMIDE DERIVATIVES AND RELATED COMPOUNDS AS BETA-SECRETASE INHIBITORS FOR TREATING

The present invention provides novel beta-secretase inhibitors and methods for their use, including methods of treating of Alzheimer's disease. (Formula)